Sustained-release drug delivery system

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/135 (2006.01) A61K 9/20 (2006.01) A61K 9/22 (2006.01) A61K 31/137 (2006.01)

Patent

CA 2238930

A sustained-release pharmaceutical composition comprising a highly soluble pharmaceutical agent, such as selegiline, in a pharmaceutical carrier comprising a hydrophilic polymer dispersed in a hydrophobic matrix. A hydrophilic microenvironment is created in a hydrophobic matrix by incorporating hydrophilic polymers within a hydrophobic matrix. Optionally, a binder, preferably a polyhydroyxlated compound, can also be added.

Composition pharmaceutique à libération prolongée comprenant un agent pharmaceutique hautement soluble tel que la sélégiline, dans un excipient pharmaceutique comprenant un polymère hydrophile dispersé dans une matrice hydrophobe. Un microenvironnement hydrophile est créé dans une matrice hydrophobe par incorporation de polymères hydrophiles à l'intérieur d'une matrice hydrophobe. On peut également ajouter, à titre d'option, un liant, de préférence un composé polyhydroxylé.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Sustained-release drug delivery system does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sustained-release drug delivery system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained-release drug delivery system will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1935274

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.